Overview

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation therapy for locally advanced cervical cancer.
Phase:
Phase 1
Details
Lead Sponsor:
University of Miami
Treatments:
Cisplatin
Nelfinavir